DUCRAY KERTYOL PSO Concentrate, 100 ml

Instructions for use for DUCRAY KERTYOL PSO Concentrate, 100 ml

Directions for use of the product Ducray Kertyol P.S.O Concentrate: - Ducray Kertyol P.S.O Concentrate is a specially formulated product for the complementary care of dry, stubborn plaques on the body and scalp. - The concentrate improves the appearance of dry and stubborn plaques, strengthens the skin barrier, soothes itching and relieves redness. It dissolves dead skin cells and reduces plaque thickening. - For use on the body, the concentrate is applied 1-2 times a day during the intensive care phase and 2 times a week during the maintenance phase. On the scalp, it is applied during the intensive care phase, left to act overnight and rinsed out the next day with a mild shampoo. In the maintenance phase, it is also used 2 times a week. - Avoid getting the concentrate in the eyes and always use a sunscreen during application. The efficacy of the product has been proven over a period of 8 weeks and it has been designed to minimise the risk of allergic reactions. - The ingredients of the concentrate include glycolic acid, lactamide, védérine, celastrol, polidocanol and ichtoyl. - Studies have shown that Kertyol P.S.O concentrate reduces the thickness of plaques and significantly reduces itching. - The concentrate can be used in combination with medical treatments and has been found to be very well tolerated. - The full list of ingredients includes Water (Aqua), Ethylhexyl Palmitate, Glycerin, Cetearyl Alcohol, Lactamide Mea, Dimethicone, Glycolic Acid, Glyceryl Stearate Ceteareth-33, Hydroxyethyl Acrylate / Sodium Acryloyldimethyl Taurate Copolymer, Laureth-9, 1,2-Hexanediol, Caprylyl Glycol, Cichorium Intybus (Chicory) Root Extract, Ethanolamine, Fragrance (Parfum), Hydrogenated Polyisobutene, PEG-7 Trimethylolpropane Coconut Ether, Pentylene Glycol, Sodium Chloride, Sodium Hydroxide, Sodium Shale Oil Sulfonate, Sorbitan Isostearate, Tripterygium Qilfordii Callus Extract. Source: Packaging information (as of 04/2020)